Cargando…
HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
HuR is an mRNA-binding protein whose overexpression in cancer cells has been associated with poor prognosis and resistance to therapy. While reports on HuR overexpression contributing to chemoresistance exist, limited information is available on HuR and radioresistance especially in triple-negative...
Autores principales: | Mehta, Meghna, Basalingappa, Kanthesh, Griffith, James N., Andrade, Daniel, Babu, Anish, Amreddy, Narsireddy, Muralidharan, Ranganayaki, Gorospe, Myriam, Herman, Terence, Ding, Wei-Qun, Ramesh, Rajagopal, Munshi, Anupama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323119/ https://www.ncbi.nlm.nih.gov/pubmed/27588488 http://dx.doi.org/10.18632/oncotarget.11706 |
Ejemplares similares
-
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
por: Muralidharan, Ranganayaki, et al.
Publicado: (2016) -
Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment
por: Amreddy, Narsireddy, et al.
Publicado: (2017) -
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
por: Amreddy, Narsireddy, et al.
Publicado: (2015) -
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
por: Muralidharan, Ranganayaki, et al.
Publicado: (2017) -
HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A
por: Andrade, Daniel, et al.
Publicado: (2019)